Catalyst Wire Dossier Catalyst Wire Dossier

4 mg prototype mini nicotine lozenge

nicotine lozenge · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 4 mg prototype mini nicotine lozenge, covering 2019-12-04 to 2019-12-04. Get the full timeline:

Most recent: Clinical Trial Update: To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers [Phase 1]

See pricing